Heparin and several other sulphated polysaccharides probably act as blood anticoagulants by potentiating the activity of antithrombin 111 against coagulation-cascade proteinases. The same compounds prevent the inhibition of thrombin (EC 3.4.2 1.5) in vitro by two other plasma proteinase inhibitors, a,proteinase inhibitor (Danishefsky & Pixley, 1979; Long & Williamson, 198 al., 1979, 1980) . fails to affect their inhibition in oitro by a,proteinase inhibitor.
Sources of a,-proteinase inhibitor, substrate for thrombin (Long & Williamson, 1981) , plasmin, substrate for plasmin (Kindness et al., 1980) , and other materials (Kindness et al., 1979) have been previously described. To examine the inhibition of thrombin and factor X, by a,-proteinase inhibitor, a mixture of 20pl of' heparin and 20pl of enzyme (thrombin, 6 unitdml; factor X,, 2 units/ml) was incubated at 2OoC for 5min before addition of 20p1 of a,-proteinase inhibitor (2mg/ml) and re-incubation of the mixture at 37OC (for thrombin, 90min; for factor X,, 30min). Then 40p1 of the mixture was added to 360pl of a solution containing chromogenic substrate (0.15 mg/ ml; compounds S-2238 for thrombin and S-2222 for factor X,), Polybrene (0.1 mg/ml) and Tris/HCI buffer (150mh4, pH 7.2). Reactions were stopped after incubation for a further 5min (thrombin) or 15min (factor X,). To examine the inhibition of plasmin by a,-proteinase inhibitor, a mixture of 1OOpl of heparin and IOOpl of plasmin (0.16 units/ml) was incubated at 2OoC for 5 min before addition of loop1 of a,-proteinase inhibitor (0.3mg/ml) and re-incubation of the mixture at 37OC for 180min. The 1OOpl of a mixture containing compound S-2251 (0.6 mg/ml), Polybrene (0.6 rng/ml) and Tris/HCl buffer (150mM, pH7.2) was added. The reaction was stopped after a further 5 min incubation. Proteinase, a,-proteinase inhibitor and heparin concentrations are expressed as final concentrations in the mixture before substrate addition. Reactions were stopped by addition of 150p1 of 50% (v/v) acetic acid. p-Nitroaniline released was determined spectrophotometrically and expressed as a percentage of that released in the absence of inhibitor or heparin. In the absence of heparin, rates of thrombin-, factor Xu-and plasmin-catalysed reactions were decreased to 47%, 26% and 53% respectively, under the conditions of antiproteinase treatment described. Absorbances of p-nitroaniline released from compounds S-2238, S-2222 and S-2251 in the absence of inhibitor or heparin were in the ranges of 0.66-0.70, 0.30-0.34 and 0.48-0.5 1 respectively.
After preliminary experiments, conditions resulting in substantial inhibition of each enzyme were selected, and, under these conditions, experiments repeated in the presence of various heparin concentrations. Fig. 1 shows that heparin prevented the inhibition by a,-proteinase inhibitor of the thrombin-catalysed reaction, but did not affect the inhibition of the factor Xu-or plasmin-catalysed reactions. Incubation of heparin with proteinases in the absence of inhibitor did not affect the rate of the reactions. No amidolysis occurred in control tubes that lacked proteinases but contained, separately or together, heparin and inhibitor. Structural requirements in sulphated polysaccharides for anticoagulation, for antithrombin-111 potentiation and for prevention of the thrombin inhibition by a,-proteinase inhibitor appear to be similar (Danishefsky & Pixley, 1979; Long & Williamson, I98 1). Because the latter effect presumably involves an interaction between heparin and the proteinase (Danishefsky & Pixley, 1979) , such data are consistent with the possibility that a direct polysaccharide-proteinase interaction may be required at some stage of polysaccharide-modulated antithrombin-I11 inhibition of thrombin. The inability of heparin to affect the inhibition of plasmin and factor X, by a,-proteinase inhibitor accords with the report that these enzymes bind to heparin with low avidity (Jordan et al., 1980) , and with the suggestion that heparin-modulated antithrombin-111 inhibition of factor X, may not require a polysaccharide-proteinase interaction (Holmer et al., 1980 
